Item 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans of Directors and Executive Officers

The following table describes any contracts, instructions or written plans for the sale or purchase of Equifax securities and intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act that were adopted by our directors and executive officers during the quarter ended June 30, 2025:


Name and Title	Date of Adoption of Rule 10b5-1 Trading Plan	Scheduled Expiration Date of Rule 10b5-1 Trading Plan(1)	Aggregate Number of Securities to Be Purchased or Sold
Jamil Farshchi, Executive Vice President, Chief Technology Officer	4/25/2025	2/20/2026	Sale of up to 13,231 shares of common stock in multiple transactions
John W. Gamble, Jr., Executive Vice President, Chief Financial Officer and Chief Operations Officer	5/14/2025	11/20/2025	Sales of up to 18,385 shares of common stock in multiple transactions
Carla J. Chaney, Executive Vice President, Chief Human Resources Officer	5/14/2025	2/20/2026	Sale of up to 6,697 shares of common stock in multiple transactions
Julia A. Houston, Executive Vice President, Chief Legal Officer	5/21/2025	11/28/2025	Sale of up to 5,500 shares of common stock in multiple transactions
James M. Griggs, Chief Accounting Officer and Corporate Controller	5/21/2025	2/27/2026	Sale of up to 1,605 shares of common stock in multiple transactions

During the quarter ended June 30, 2025, none of our directors or executive officers terminated a Rule 10b5-1 trading plan or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS